Litcius/Paper detail

Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder

Mitchell G. Miglis, Charles H. Adler, Elena Antelmi, Dario Arnaldi, Luca Baldelli, Bradley F. Boeve, Matteo Cesari, Irene Dall’Antonia, Nico J. Diederich, Kathrin Doppler, Petr Dušek, Raffaele Ferri, Jean‐François Gagnon, Ziv Gan‐Or, Wiebke Hermann, Birgit Högl, Michele T Hu, Álex Iranzo, Annette Janzen, Anastasia Kuzkina, Jee‐Young Lee, Klaus L. Leenders, Simon J.G. Lewis, Claudio Liguori, Jun Liu, Christine Lo, Kaylena A. Ehgoetz Martens, Jiří Nepožitek, Giuseppe Plazzi, Federica Provini, Monica Puligheddu, Michal Rolinski, Jan Rusz, Ambra Stefani, Rebekah L. S. Summers, Dallah Yoo, Jennifer Zitser, Wolfgang H. Oertel

2021The Lancet Neurology242 citationsDOIOpen Access PDF

Topics & Concepts

SynucleinopathiesDementia with Lewy bodiesRapid eye movement sleepDiseaseDementiaNeuroscienceParkinson's diseaseAtrophyMedicineREM sleep behavior disorderEye movementAlpha-synucleinPathologyPsychologyParkinson's Disease Mechanisms and TreatmentsOlfactory and Sensory Function StudiesBotulinum Toxin and Related Neurological Disorders
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder | Litcius